About Lunit
Lunit is a leading medical AI software company dedicated to advancing total cancer care through innovative artificial intelligence solutions. Their comprehensive platform integrates AI across the entire cancer care continuum, from early detection and diagnosis to personalized treatment decisions and drug development.
For diagnostic imaging, Lunit offers the INSIGHT suite, which includes AI solutions for chest X-rays (Lunit INSIGHT CXR), mammography (Lunit INSIGHT MMG), and 3D digital breast tomosynthesis (Lunit INSIGHT DBT). These tools are designed to assist radiologists by enhancing the accuracy and efficiency of cancer screening and detection, identifying subtle abnormalities that might be missed by the human eye. The company’s solutions are clinically validated and have received FDA clearance and CE Mark certification, demonstrating their reliability and efficacy in real-world clinical settings globally.
In the realm of precision oncology, Lunit’s SCOPE platform provides AI-powered biomarker analysis for immuno-oncology. This includes solutions like Lunit SCOPE IO for tumor microenvironment analysis, Lunit SCOPE PD-L1 for PD-L1 expression quantification, and Lunit SCOPE IHC Suite for IHC quantification. These tools aid pathologists and researchers in predicting patient responses to immunotherapy, guiding treatment strategies, and accelerating the discovery and development of new antibody-based therapies and companion diagnostics. Lunit partners with global healthcare and biopharma leaders to deploy its AI products and drive innovation in cancer care.
Focus Areas
Business Intelligence
| Technology | cloud-native, multimodal AI approach, foundation models, AI-powered medical image analytics, AI biomarkers, deep learning technology, NVIDIA Tensor Core GPUs (including NVIDIA A100 GPUs), NVIDIA Jetson edge AI platform, NVIDIA TensorRT software |
What Physicians Need to Know
For physicians, Lunit's AI solutions act as a powerful 'second pair of eyes,' significantly enhancing diagnostic confidence and accuracy by detecting 5-13% more cancers in mammography and identifying subtle abnormalities in chest X-rays that might otherwise be overlooked. This leads to earlier detection, which is crucial for improved patient outcomes and can reduce unnecessary patient callbacks. The AI streamlines workflows by providing faster image interpretation, reducing cognitive load, and enabling efficient triage, which is particularly beneficial in high-volume settings or amidst radiologist shortages. In oncology, Lunit SCOPE offers quantifiable insights from tissue, aiding in biomarker discovery and personalized treatment strategies. The systems are designed for seamless integration into existing PACS/RIS and clinical workflows, minimizing disruption and maximizing utility. Furthermore, the extensive clinical validation and regulatory approvals (FDA, CE-MDR) provide a strong foundation of trust and reliability for clinical adoption.
Lunit's AI solutions are built for seamless and stable integration into existing radiology and pathology environments. They are compatible with standard DICOM formats and integrate with leading imaging manufacturers, PACS/RIS vendors, and digital health platforms. Key partnerships include collaborations with GE Healthcare (e.g., Thoracic Care Suite, Centricity PACS, Edison Open AI Orchestrator), Fujifilm, and cloud-based PACS providers like Emergent Connect, ensuring flexible deployment options and dedicated technical support.
What the Web Says
Lunit is a South Korean medical AI company specializing in cancer diagnostics and therapeutics, particularly with its INSIGHT suite for analyzing chest X-rays and mammograms. The company's products are designed to assist radiologists in detecting early signs of cancer, prioritizing urgent cases, and improving workflow efficiency. Lunit's AI has demonstrated high accuracy in detecting various abnormalities, including tuberculosis, and has received positive feedback for its potential to reduce radiologist workload and enhance diagnostic precision.
Overall: PositiveStrengths
- High accuracy in cancer detection (97-99%) and abnormality identification.
- Reduces radiologist workload and improves efficiency.
- Aids in early detection and prioritization of urgent cases.
- Seamless integration into existing medical imaging workflows.
- Strong clinical validation through numerous studies and collaborations.
- Maintains high sensitivity across diverse populations and thresholds, crucial for resource-limited settings.
Limitations
- Pricing information is not publicly available and requires direct contact.
- Limited details on inputs/outputs or integration from available information.
- Deployment depth may vary by health system.
- Some Reddit discussions express concern about AI potentially replacing radiologists.
- Accuracy claims should be independently verified.
Based on reviews from: Elion, Neura Market, Techjockey.com, SoftFinders, Slashdot, Clinical Trials Arena, The Lancet Digital Health, Indeed.com, Reddit, ResponsibilityReports.com
Last updated: 2026-07-18
Videos
News, demos, and interviews about Lunit.
Videos load interactively. If none appear, search YouTube for Lunit →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Lunit.
Comparisons
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]
Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]